Centene price target raised to $40 from $32 at Goldman Sachs

Goldman Sachs analyst Scott Fidel raised the firm’s price target on Centene (CNC) to $40 from $32 and keeps a Sell rating on the shares. Centene rallied after a Q1 beat and full-year guidance raise, driven by favorable seasonal factors and early signs of improved cost control and margin stabilization across Medicaid and Medicare, the analyst tells investors in a research note.